Vaccines

KHN’s ‘What the Health?’: FDA Takes Center Stage

KFF Health News Original

Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.

Missouri’s War on Public Health Shows Extent of National Rift

KFF Health News Original

A public health official who said he was anti-abortion and anti-mandate for masks and covid vaccines did not pass the purity test of a Missouri senator who opposes covid public health restrictions. The senator killed the official’s nomination to be state health director, highlighting how hands may be tied in the nationwide fight against infectious diseases.

KHN’s ‘What the Health?’: Record ACA Enrollment Puts Pressure on Congress

KFF Health News Original

Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of “The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having — Or Being Denied — An Abortion.”

With a Vaccine Mandate Looming, Nursing Homes Face More Staffing Problems

KFF Health News Original

Missouri has the worst covid-19 vaccination rate for nursing home health care workers in the nation. There, the federal mandate for workers to get vaccinated — upheld by the U.S. Supreme Court — reveals the problems that operators have hiring staff, keeping them, and providing decent care.

Vaccine Wars Ignite in California as Lawmakers Seek Stronger Laws

KFF Health News Original

Anti-vaccination activists say California’s Democratic lawmakers are helping strengthen their movement nationally by pushing for tougher vaccine requirements — without exemptions for religious or personal beliefs. But a new pro-vaccine lobbying force is vowing to fight back.

KHN’s ‘What the Health?’: Roe v. Wade’s (Possibly Last) Anniversary

KFF Health News Original

Jan. 22 marks the 49th — and very likely last — anniversary of the Supreme Court’s landmark abortion decision, Roe v. Wade. The court’s conservative supermajority seems poised to overturn later this year the ruling that legalized abortion nationwide. Also this week, the Biden administration turns 1, with much of its domestic and health agenda yet unrealized. Alice Miranda Ollstein of Politico, Shefali Luthra of the 19th, and Kimberly Leonard of Insider join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Marjorie Dannenfelser, president of the Susan B. Anthony List, about what a post-Roe world might look like.

As Omicron Surges, Effort to Vaccinate Young Children Stalls

KFF Health News Original

Just 18% of 5- to 11-year-olds are fully vaccinated, with rates varying significantly across the country, a KHN analysis of federal data shows. Pediatricians say the slow pace and geographic disparities are alarming, especially against the backdrop of record numbers of cases and pediatric hospitalizations.

KHN’s ‘What the Health?’: Dealing With Drug Prices

KFF Health News Original

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.